Table 3 PRO patient population included in the PRO analyses.

From: Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvement

PRO evaluable population definition Trials (N = 17), n (%)
Safety population with baseline and at least one post-baseline assessment 1 (6)
Safety population 2 (12)
ITT patients with baseline and at least one post-baseline assessment 2 (12)
ITT 7 (41)
Patients with at least one post-baseline assessment and 50% completion of the relevant items for a domain 2 (12)
At least one assessment 2 (12)
ITT patients receiving active treatment and at least one PRO measurement item completed 1 (6)
  1. ITT intent to treat.